The highest dose group (4 mg) eliciting systemic IFN-γ responses in the absence of inflammatory responses may indicate that this pathway may also exert an effect on systemic viral infection, and further dose increase is possible when respiratory viral infection spills into systemic organs. Here, IFNG is linked to viral infectious disease.